ROSSI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 977
EU - Europa 400
AS - Asia 331
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.712
Nazione #
US - Stati Uniti d'America 976
CN - Cina 185
UA - Ucraina 131
DE - Germania 85
GB - Regno Unito 55
SG - Singapore 50
FI - Finlandia 45
HK - Hong Kong 44
IT - Italia 42
IN - India 21
IE - Irlanda 19
TR - Turchia 18
CZ - Repubblica Ceca 7
FR - Francia 6
RU - Federazione Russa 6
IR - Iran 3
KG - Kirghizistan 3
AU - Australia 2
BD - Bangladesh 2
JP - Giappone 2
EU - Europa 1
IM - Isola di Man 1
LV - Lettonia 1
MU - Mauritius 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SE - Svezia 1
TJ - Tagikistan 1
VN - Vietnam 1
Totale 1.712
Città #
Fairfield 129
Woodbridge 122
Jacksonville 96
Houston 77
Seattle 63
Ashburn 57
Cambridge 57
Ann Arbor 55
Wilmington 49
Hong Kong 44
Princeton 38
Singapore 37
Beijing 36
Lancaster 36
Chandler 32
Nanjing 32
New York 23
Helsinki 21
Dearborn 20
Dublin 19
Istanbul 18
Brescia 16
Hebei 16
Des Moines 13
Jinan 12
Shenyang 12
Nanchang 10
Shanghai 10
Taizhou 9
Tianjin 9
Changsha 8
San Diego 7
San Mateo 7
Munich 6
Verona 6
Espoo 5
Milan 5
Ningbo 5
Brno 4
Hangzhou 4
Leawood 4
San Francisco 4
Bishkek 3
Guangzhou 3
Haikou 3
Olomouc 3
Zhengzhou 3
Ardabil 2
Dhaka 2
Fuzhou 2
Jiaxing 2
Kilburn 2
Kunming 2
Lanzhou 2
London 2
Norwalk 2
Treviglio 2
Bangalore 1
Berlin 1
Boardman 1
Bollate 1
Douglas 1
Dushanbe 1
Frankfurt am Main 1
Guiyang 1
Gunzenhausen 1
Hanover 1
Islamabad 1
Latina 1
Leipzig 1
Lisbon 1
Los Angeles 1
Melbourne 1
Middlesbrough 1
Monmouth Junction 1
Newark 1
Nürnberg 1
Orange 1
Prescot 1
Riga 1
Saigon 1
Santa Clara 1
Secaucus 1
Southwark 1
Sydney 1
Taurianova 1
Tokyo 1
Wandsworth 1
Washington 1
Xian 1
Totale 1.301
Nome #
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 144
Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems 136
Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma 130
CAVEOLIN-1 IS A MARKER OF POOR DIFFERENTIATION IN RHABDOMYOSARCOMA 116
Point mutated Caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature 115
The cytosolic sialidase Neu2 is degraded by autophagy during myoblast atrophy. 115
Phenotypic behavior of C2C12 myoblasts upon expression of the dystrophy-related caveolin-3 P104L and TFT mutants 105
Rhabdomyosarcomas: an overview on the experimental animal models. 105
Defective myogenic differentiation of human rhabdomyosarcoma cells is characterized by sialidase Neu2 loss of expression. 103
Caveolins in rhabdomyosarcoma 100
The enzymatic activity of sialidase Neu2 is inversely regulated during in vitro myoblast hypertrophy and atrophy. 95
The cytosolic sialidase Neu2 is substrate of degradation by autophagy during myoblast atrophy 74
DORSOMORPHIN, A SELECTIVE INHIBITOR OF SMAD1/5/8 PHOSPHORYLATION, IS A POTENT ENHANCER OF MYOBLAST DIFFERENTIATION 70
CAVEOLIN-1 PROMOTES PROLIFERATION AND CONFERS RESISTANCE TO OXIDATIVE STRESS-INDUCED CELL DEATH IN RHABDOMYOSARCOMA CELLS 68
Developmental expression of the sialidase Neu2 ortholog gene in zebrafish and characterization of the knock-down model. 65
The expression of Caveolin-3 and its related Limb Girdle Muscular Dystrophy 1-c mutants in myoblasts: physiological and pathological aspects 65
FUNCTIONAL ANTAGONISM BETWEEN P38 AND MYOSTATIN PATHWAYS IN RHABDOMYOSARCOMA CELLS 60
Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and ERK signalling pathways 58
L6E9 Myoblasts Are Deficient of Myostatin and Additional TGF-βMembers Are Candidates to Developmentally Control Their FiberFormation 56
Totale 1.780
Categoria #
all - tutte 8.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020328 0 0 0 0 27 53 57 49 43 56 17 26
2020/2021250 7 29 11 25 9 27 4 30 40 22 38 8
2021/2022168 5 38 2 1 0 3 11 7 3 31 29 38
2022/2023127 19 3 8 3 6 31 0 13 20 0 9 15
2023/2024169 10 6 22 7 7 26 10 4 48 1 2 26
2024/202599 7 1 0 52 39 0 0 0 0 0 0 0
Totale 1.780